Skip to main content

Table 3 Medical characteristics of the participants

From: Hepatitis C reinfection in former and active injecting drug users in Belgium

Characteristics N (%)
HIV coinfection 0
Fibrosis  
       F0–F1 27 (43.5)
       F2 12 (19.4)
       F3 13 (21.0)
       F4 8 (12.9)
       Missing 2 (3.2)
Genotype  
       1a 31 (51.7)
       1b 7 (11.7)
       3 9 (15.0)
       4 5 (8.3)
       Missing 8 (13.3)
Year end of treatment  
      2015 1 (1.7)
       2016 6 (10.0)
       2017 7 (11.7)
       2018 9 (15.0)
       2019 30 (50.0)
       2020 7 (11.7)